Ignite Creation Date:
2024-05-06 @ 7:49 PM
Last Modification Date:
2024-10-26 @ 3:14 PM
Study NCT ID:
NCT06149130
Status:
RECRUITING
Last Update Posted:
2024-04-15
First Post:
2023-11-20
Brief Title:
Adebrelimab Combined With Dalpiciclib and Standard Endocrine Therapy for HRHER2 - Advanced Breast Cancer
Sponsor:
Organization:
Tongji Hospital